-transparent.png){kind=logo}
Intravesical chemotherapy with sequential instillation of mitomycin C and adriamycin was carried out on 19 patients with superficial bladder cancer (Ta, T1 and Tis). Twenty milligram of mitomycin C on day 1 and 40 mg of adriamycin on day 2 were instilled into the bladder, this treatment being repeated weekly for 5 consecutive weeks if there were no serious side effects. The following results were obtained. Of 16 evaluable patients, 10 patients (63%) achieved complete response and 2 patients achieved partial response, 4 patients showing no response. In patients with high grade tumor, especially with carcinoma in situ, a high CR rate (6/7 or 86%) was achieved. Chemical cystitis occurred in 10 out of 19 (53%) patients. In 5 of the 6 patients who suffered from severe cystitis symptoms, treatment was discontinued. However, the symptoms resolved within 4 weeks in all patients.
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
January 1992,
Cancer chemotherapy and pharmacology,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
January 1999,
Khirurgiia,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
June 1987,
Gan to kagaku ryoho. Cancer & chemotherapy,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
January 1989,
Progress in clinical and biological research,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
January 1987,
Cancer chemotherapy and pharmacology,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
September 1986,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
June 1989,
The Journal of urology,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
January 1991,
European urology,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
May 2001,
The Kaohsiung journal of medical sciences,
I Fukui, and
H Sekine, and
T Yamada, and
K Kihara
January 1982,
European urology,
